Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
All Stories
RESPONSIBILITY
11.24.2020
How Some Black Women Experience Cancer, COVID and the Healthcare System
A Q&A with Maimah Karmo, CEO of the Tigerlily Foundation, and global advocate for young Black women with breast cancer.
Read more
All Stories
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
LEADERSHIP
12.14.2020
Amgen CEO Bob Bradway Highlights Advances Against COVID-19 and Other Diseases at Major Healthcare Conferences
PEOPLE & CULTURE
11.19.2020
In Asia, COVID-19 Sparked a Transformation for Medical Affairs
PEOPLE & CULTURE
11.09.2020
Her Mom Died from COVID-19. This Is What Was Lost.
LEADERSHIP
10.30.2020
CEO Bob Bradway Praises Manufacturing Teams in Puerto Rico Focused on Patient Supply
PATIENTS
10.28.2020
Support for Breast Cancer Survivors, Including One on Our Team
PATIENTS
10.23.2020
Amgen and CDC Foundation Are Working Together to Encourage Medical Visits During Pandemic
PEOPLE & CULTURE
10.23.2020
Vintage-Inspired Posters Encourage Amgen Staff to Avoid COVID-19 Complacency
LEADERSHIP
10.20.2020
At Milken Global Conference, Amgen CEO Bob Bradway Urges More Attention to Predicting and Preventing Chronic Disease Amid COVID-19 Pandemic
PEOPLE & CULTURE
10.19.2020
How Some Amgen Scientists, Researchers Navigate COVID-19 Complacency
SCIENCE & INNOVATION
09.01.2020
Large deCODE Study Tests Durability of Antibody Response to SARS-CoV-2 Infection
PEOPLE & CULTURE
08.20.2020
Serving COVID Patients in Intensive Care in Sweden
PEOPLE & CULTURE
08.18.2020
Pitching In to Keep the Assembly Line Moving
SCIENCE & INNOVATION
07.23.2020
Global Network of Adaptive Clinical Trials Is Helping Fight COVID-19
PATIENTS
07.22.2020
How One Heart Failure Patient Navigates Her Care During the Pandemic
RESPONSIBILITY
07.21.2020
Amgen Foundation Expands Partnership With Khan Academy
LEADERSHIP
07.16.2020
CEO Bob Bradway Discusses Industry’s COVID-19 Response at
Fortune
Conference
PEOPLE & CULTURE
07.09.2020
This Small but Mighty Amgen Facility Set the Bar with Its COVID-19 Response
PEOPLE & CULTURE
06.22.2020
Pandemic Pods and New Product Launches
PEOPLE & CULTURE
06.15.2020
The Woman Behind Amgen Ventures
PEOPLE & CULTURE
06.10.2020
Answering the Public’s Questions About COVID-19–While the Earth Shakes
Load more
Loading...